Duodenal levodopa infusion: Safety and efficacy in a 6 years outpatient follow-up
Objective: To reduce the risk of adverse events and dropout rate in patients. Background: Duodenal levodopa infusion (DLI) is used for the treatment of advanced…Exercise-induced adaptive neuroplasticity in the MPTP mouse model of Parkinson’s disease
Objective: To increase our understanding of how physical exercise may drive adaptive neuroplasticity in a mouse model of Parkinson's disease (PD). Background: PD is a…Mobile decision support system for nurse managment of deep brain stimulation
Objective: To decrease time spent on deep brain stimulation (DBS) programming while improving quality of life for patients and caregivers by providing nurses with an…Critical path for Parkinson’s, I: Data sharing and regulatory science in catalyzing innovation for Parkinson’s disease
Objective: This presentation highlights a new precompetitive consortium based strategy for the successful development of regulatory-endorsed biomarkers and quantitative drug development platforms targeted at the…Feasibility and preliminary efficacy of a telehealth approach to group tango instruction for people with Parkinson’s disease
Objective: To determine the feasibility and preliminary efficacy of group adapted tango class for individuals with Parkinson's disease (PD) taught through telehealth technology. Background: Group…Blindfolded balance training in patients with Parkinson’s disease: A sensory-motor strategy to improve the gait
Objective: Recent evidence suggested that the use of treadmill training may improve gait parameters, such as gait speed and stride length. Visual deprivation could engage…Objective measures of Parkinsonian motor symptoms using a continuously worn smartwatch
Objective: To determine whether smartwatch sensor data correlates with clinician-measured Parkinson's disease symptoms. Background: Data collected with smartwatches could be used for long-term, continuous assessment…Utilization and longitudinal impact of amantadine use in Parkinson’s disease. National Parkinson Foundation (NPF) QII registry
Objective: To evaluate baseline predictors and longitudinal impact of amantadine use in Parkinson's disease (PD). Background: There is preclinical data that amantadine has neuroprotective properties,…Pathological findings from two Parkinson’s disease patients after intraputaminal GDNF infusion
Objective: To describe the postmortem findings from two patients who underwent intraputaminal infusion of glial-derived neurotrophic factor (GDNF). Background: GDNF has been shown to have…Fox insight wear ecosystem: using mobile technology and cloud-based computing to support PD research
Objective: To enable a simple strategy for the continuous collection and analysis of sensory data from Parkinson's disease (PD) patients that can increase the effectiveness…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.